Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Ravi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2004 - 2007
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Kerala Medical CollegeClass of 1999
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2007 - Present
GA State Medical License 2023 - 2028
AZ State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
- Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma Start of enrollment: 2011 Nov 03
- Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study Start of enrollment: 2013 Mar 29
Publications & Presentations
PubMed
- Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications.David Z Allen, S Mohsen Hosseini, Mark Zafereo, Miriam Lango, Elizabeth Gardner Grubbs
Head & Neck. 2026-08-01 - Primary Synovial Sarcoma of the Abdomen and Pelvis.Riddhi R Patel, Jonathan Feit, Grace Werling, Nora M White, Andrew J Bishop
American Journal of Clinical Oncology. 2026-07-01 - 1 citationsPimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.Hairong Xu, Xiaohui Niu, Vinod Ravi, Javier Martin-Broto, Albiruni Abdul Razak
Lancet. 2026-03-14
Lectures
- Artificial Intelligence (AI) and machine learning (ML) in risk prediction of hospital acquired pressure injuries (HAPIs) among oncology inpatients.2019 ASCO Annual Meeting - 6/1/2019
- TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Genomic subtypes of angiosarcoma: A comprehensive genomic profiling (CGP) study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapyRavi V, Raut CP, Patel SR, DeLaney TF
http://www.uptodate.com/contents/desmoid-tumors-epidemiology-risk-factors-molecular-pathogenesis-cli
UpToDate, Wolters Kluwer Health - 2012-10-26 - Desmoid tumors: Systemic therapyRavi V, Patel SR
http://www.uptodate.com/contents/desmoid-tumors-systemic-therapy
UpToDate, Wolters Kluwer Health - 2012-03-22
Press Mentions
The Diagnosis That Saved Me — and May Have Misled My Mother to Her DeathSeptember 10th, 2025- At ASCO, Merck KGaA Shows How Its Drug Measures up as Treatment for Rare Type of TumorJune 1st, 2025
A Pilot Study of Oraxol in Subjects with Cutaneous AngiosarcomaJune 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
